News

Published on 7 Mar 2024 on Simply Wall St. via Yahoo Finance

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 39% Below Their Intrinsic Value Estimate


Article preview image

Key Insights

The projected fair value for Mesa Laboratories is US$189 based on 2 Stage Free Cash Flow to EquityCurrent share price of US$114 suggests Mesa Laboratories is potentially 39% undervaluedOur fair value estimate is 48% higher than Mesa Laboratories' analyst price target of US$127

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Mesa Laboratories, Inc. (NASDAQ:MLAB) as an investment opportunity by estimating the company's future cash flows and discounting them to their present value. Our analysis will employ the Discounted Cash Flow (DCF) model. There's really not all that much to it, even though it might appear quite complex.

NASDAQ.MLAB price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Potentially Undervalued?

Mesa Laboratories, Inc. (NASDAQ:MLAB), might not be a large cap stock, but it led the NASDAQGS...

Simply Wall St. · via Yahoo Finance 6 Jan 2025

Analysis of Chuck Royce's Recent Transaction in Mesa Laboratories Inc

Overview of Chuck Royce (Trades, Portfolio)'s Recent Trade Warning! GuruFocus has detected 10 War...

GuruFocus.com · via Yahoo Finance 15 Oct 2024

The past three years for Mesa Laboratories (NASDAQ:MLAB) investors has not been profitable

Mesa Laboratories, Inc. (NASDAQ:MLAB) shareholders should be happy to see the share price up 12% ...

Simply Wall St. via Yahoo Finance 18 Apr 2024

Best Value Stocks to Buy for April 8th

Here are two stocks with buy rank and strong value characteristics for investors to consider toda...

Zacks via Yahoo Finance 8 Apr 2024

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 39% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Mesa Laboratories is US$189 based on 2 Stage Free Cash ...

Simply Wall St. via Yahoo Finance 7 Mar 2024

Mesa Laboratories (MLAB) Impacted by Slowdown in Pharmaceutical And Biotech Spending

Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” fourth...

Insider Monkey via Yahoo Finance 19 Feb 2024

Results: Mesa Laboratories, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

As you might know, Mesa Laboratories, Inc. (NASDAQ:MLAB) recently reported its quarterly numbers....

Simply Wall St. via Yahoo Finance 8 Feb 2024

Mesa Laboratories Inc (MLAB) Faces Revenue Dip Amidst Strategic Acquisitions

Revenue: Reported a slight decrease of 1.5% year-over-year to $53,473 thousand.Net Income: Experi...

GuruFocus.com via Yahoo Finance 5 Feb 2024

What Is Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Share Price Doing?

Mesa Laboratories, Inc. (NASDAQ:MLAB), is not the largest company out there, but it saw a decent ...

Simply Wall St. via Yahoo Finance 5 Jan 2024

Mesa Laboratories Inc (MLAB) Reports 9.5% Decrease in Q2 FY 2024 Revenues

Mesa Laboratories Inc (NASDAQ:MLAB) reports a 9.5% decrease in total revenues for Q2 FY 2024 comp...

GuruFocus.com via Yahoo Finance 7 Nov 2023